← Back
$WGS All transactions

GeneDx Holdings Corp.

▼ SELL 10b5-1 Plan

$ Value

$560K

Shares

5,163

Price

$109

Filed

Oct 1

Insider

Name

Stueland Katherine

Title

CHIEF EXECUTIVE OFFICER

CIK

0001689575

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,255

Footnotes

The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.558, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.98, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.9955, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.99, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.3837, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive. | Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 1,720 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms.

Filing Info

Accession No.

0001689575-25-000010

Form Type

4

Issuer CIK

0001818331

Stueland Katherine's History

Date Ticker Type Value
2026-03-26 WGS M $0
2026-03-26 WGS $811K
2026-03-26 WGS $319K
2026-03-26 WGS $849K
2026-03-26 WGS $342K
2026-03-26 WGS $645K
2026-03-26 WGS M $0
2026-01-29 WGS M $0
2026-01-29 WGS $155K
2026-01-29 WGS M $0

Other Insiders at WGS (90d)

Insider Bought Sold Last
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$3.1M 2026-03-26
Feeley Kevin
CHIEF FINANCIAL OFFICER
$587K 2026-03-26
Dechairo Bryan
Chief Operating Officer
$851K 2026-02-04